Search research articles
Contact Us
Filters
Showing results (61-70 of 103) with videos related to
Page
of 11
Sort By:
Entropy (Basel, Switzerland)
|
December 3, 2020
The Influence of Different Knowledge-Driven Methods on Landslide Susceptibility Mapping: A Case Study in the Changbai Mountain Area, Northeast China
Zhongjun Ma, Shengwu Qin, Chen Cao, et al.
Molecular Medicine (Cambridge, Mass.)
|
January 6, 2021
Role of long non-coding RNA H19 in therapy resistance of digestive system cancers
Jingting Wang, Xiao Ma, Hai Si, et al.
Steroids
|
December 27, 2011
Physalins with anti-inflammatory activity are present in Physalis alkekengi var. franchetii and can function as Michael reaction acceptors
Long Ji, Yonglei Yuan, Liping Luo, et al.
Journal of Medicinal Chemistry
|
January 23, 2026
Design, Synthesis, and Evaluation of a Potent and Selective ROCK2 Inhibitor for Atopic Dermatitis Treatment
Churu Mao, Shuai Zhan, Zhangyun Fang, et al.
Fitoterapia
|
January 9, 2014
Novel prenylated bichalcone and chalcone from Humulus lupulus and their quinone reductase induction activities
Liyan Yu, Fuxian Zhang, Zhijuan Hu, et al.
Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP
|
December 28, 2025
Assessment of thyroid endocrine disruption induced by florfenicol: Integrating in vivo zebrafish experiments and in silico molecular docking and dynamics simulations
Zhongjun Ma, Bingkun Duan, Ying Shen, et al.
Pharmacognosy Magazine
|
June 10, 2016
Chemopreventive Agents from Physalis minima Function as Michael Reaction Acceptors
Ruizhi Men, Ning Li, Chihong Ding, et al.
Phytochemistry
|
April 26, 2011
Terpenoids from Tripterygium wilfordii
Jinzhong Xu, Juan Lu, Fang Sun, et al.
Journal of Medicinal Chemistry
|
November 9, 2023
Design, Synthesis, and Biological Evaluation of an Orally Bioavailable, Potent, and Selective ROCK2 Inhibitor for Psoriasis Treatment
Yun Huang, Chu-Ru Mao, Yijie Lou, et al.
European Journal of Medicinal Chemistry
|
January 16, 2026
Discovery of an orally bioavailable pyridone-based BRD4 inhibitor with potent antitumor efficacy in colorectal cancer
Zhangyun Fang, Shuai Zhan, Churu Mao, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 103) with videos related to
Sort By:
Page
of 11
Entropy (Basel, Switzerland)
|
December 3, 2020
The Influence of Different Knowledge-Driven Methods on Landslide Susceptibility Mapping: A Case Study in the Changbai Mountain Area, Northeast China
Zhongjun Ma, Shengwu Qin, Chen Cao, et al.
Molecular Medicine (Cambridge, Mass.)
|
January 6, 2021
Role of long non-coding RNA H19 in therapy resistance of digestive system cancers
Jingting Wang, Xiao Ma, Hai Si, et al.
Steroids
|
December 27, 2011
Physalins with anti-inflammatory activity are present in Physalis alkekengi var. franchetii and can function as Michael reaction acceptors
Long Ji, Yonglei Yuan, Liping Luo, et al.
Journal of Medicinal Chemistry
|
January 23, 2026
Design, Synthesis, and Evaluation of a Potent and Selective ROCK2 Inhibitor for Atopic Dermatitis Treatment
Churu Mao, Shuai Zhan, Zhangyun Fang, et al.
Fitoterapia
|
January 9, 2014
Novel prenylated bichalcone and chalcone from Humulus lupulus and their quinone reductase induction activities
Liyan Yu, Fuxian Zhang, Zhijuan Hu, et al.
Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP
|
December 28, 2025
Assessment of thyroid endocrine disruption induced by florfenicol: Integrating in vivo zebrafish experiments and in silico molecular docking and dynamics simulations
Zhongjun Ma, Bingkun Duan, Ying Shen, et al.
Pharmacognosy Magazine
|
June 10, 2016
Chemopreventive Agents from Physalis minima Function as Michael Reaction Acceptors
Ruizhi Men, Ning Li, Chihong Ding, et al.
Phytochemistry
|
April 26, 2011
Terpenoids from Tripterygium wilfordii
Jinzhong Xu, Juan Lu, Fang Sun, et al.
Journal of Medicinal Chemistry
|
November 9, 2023
Design, Synthesis, and Biological Evaluation of an Orally Bioavailable, Potent, and Selective ROCK2 Inhibitor for Psoriasis Treatment
Yun Huang, Chu-Ru Mao, Yijie Lou, et al.
European Journal of Medicinal Chemistry
|
January 16, 2026
Discovery of an orally bioavailable pyridone-based BRD4 inhibitor with potent antitumor efficacy in colorectal cancer
Zhangyun Fang, Shuai Zhan, Churu Mao, et al.
Page
of 11